SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 37 filers reported holding SINOVAC BIOTECH LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,078,000 | +6.6% | 802,736 | +10.2% | 0.00% | 0.0% |
| Q2 2015 | $3,825,000 | +9.5% | 728,566 | +3.4% | 0.00% | 0.0% |
| Q1 2015 | $3,494,000 | +1.0% | 704,473 | +6.5% | 0.00% | 0.0% |
| Q4 2014 | $3,461,000 | +5.9% | 661,735 | -2.6% | 0.00% | 0.0% |
| Q3 2014 | $3,269,000 | -12.0% | 679,613 | +3.2% | 0.00% | 0.0% |
| Q2 2014 | $3,714,000 | -23.8% | 658,481 | -2.8% | 0.00% | 0.0% |
| Q1 2014 | $4,876,000 | +25.8% | 677,179 | +6.9% | 0.00% | 0.0% |
| Q4 2013 | $3,876,000 | +7.9% | 633,364 | +5.5% | 0.00% | 0.0% |
| Q3 2013 | $3,591,000 | +79.6% | 600,528 | +18.0% | 0.00% | 0.0% |
| Q2 2013 | $2,000,000 | – | 508,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |